11q Deletion (del11q) Is Not a Prognostic Factor for Adverse Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Ibrutinib: Pooled Data from 3 Randomized Phase 3 Studies

Kipps T. J., Hillmen P., DEMİRKAN F., Grosicki S., Coutre S. E., Barrientos J. C., ...More

58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 128
• Doi Number: 10.1182/blood.v128.22.2042.2042
• City: California
• Country: United States Of America
• Dokuz Eylül University Affiliated: Yes